Innate Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Innate Pharma and buy or sell other stocks, options, and ETFs commission-free!About IPHA
Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Its product pipeline include Lacutamab, Monalizumab, Avdoralimab, and IPH62.
CEOHervé Eloi Dominique Brailly
CEOHervé Eloi Dominique Brailly
Employees210
Employees210
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
Founded1999
Founded1999
Employees210
Employees210
IPHA Key Statistics
Market cap229.59M
Market cap229.59M
Price-Earnings ratio-28.29
Price-Earnings ratio-28.29
Dividend yield—
Dividend yield—
Average volume9.68K
Average volume9.68K
High today$2.90
High today$2.90
Low today$2.38
Low today$2.38
Open price$2.38
Open price$2.38
Volume57.65K
Volume57.65K
52 Week high$3.57
52 Week high$3.57
52 Week low$1.81
52 Week low$1.81
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%